ClinicalTrials.Veeva

Menu

Dose Reduction in Thoracic CT

University Health Network, Toronto logo

University Health Network, Toronto

Status and phase

Completed
Phase 1

Conditions

Lymphoma

Treatments

Device: CT Thorax

Study type

Interventional

Funder types

Other

Identifiers

NCT00188461
03-0875

Details and patient eligibility

About

Hypothesis: Does a 50% reduction in radiation in dose significantly affect the diagnostic quality of chest CT

Full description

Patients with Lymphoma are recruited and have a follow up CT performed at 50% of the standard exposure parameters. The studies are compared for image quality with a recent (<3 months) thoracic CT performed at standard exposure parameters.

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Lymphoma

Exclusion criteria

  • No recent (<3 months) thoracic CT

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems